An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 65: ABP1 (7q36.1)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs1005390 4-acetamidobutanoate / X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide T/G 6520 0.8 -0.035 (0.004) 2.61·10-16 show
rs1005390 X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide T/G 7363 0.8 0.026 (0.003) 2.5·10-14 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs1005390
Chromosomal locationChr7: 150,174,654 (7q36.1)
Gene (distance)ABP1 (-5,851)
Predicted causal geneABP1 (AOC1)
Gene/protein classificationmetabolic enzyme
Metabolite (Pathway)4-acetamidobutanoate (Guanidino and acetamido metabolism; Amino acid)
X-03056--N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (Polyamine metabolism; Amino acid)
Biochemical locus-metabolite relationshipABP1 (now called AOC1) encodes a copper containing amide oxidase which can deaminate N1-acetylspermidine to produce N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). X-03056 has been annotated as N-[3-(2-oxopyrrolidin-1-yl)propyl]acetamide (acisoga). Ratio interepretation: 'selectivity'.
eQTL associationsKCNH2 (L), REPIN1 (L), TMEM176A (F) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associations-
Known metabolite associations-
Inborn error of metabolism-

Pharmacological information
ChEMBL IDCHEMBL2118
Drug information No specific drug is primarily metabolised by this enzyme; compounds with inhibitory activity in ChEMBL

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map